Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 3, 2012, Pages 235-243

  Khan, Sujoy ^a   Lynch, Nuala ^a,b  

^a FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b Hook Surgery   (United Kingdom)

Author keywords

Antihistamine; Chronic idiopathic urticaria; Leukotriene; Montelukast

Indexed keywords

ANTINUCLEAR ANTIBODY; CETIRIZINE; FEXOFENADINE; HISTAMINE; IMMUNOGLOBULIN E; LEVOCETIRIZINE; MONTELUKAST; THYROID PEROXIDASE ANTIBODY;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC IDIOPATHIC URTICARIA; CLINICAL ARTICLE; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HISTAMINE RELEASE; HUMAN; MALE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; URTICARIA;

EID: 84860433527     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812800392742     Document Type: Article

References (66)

1. Zuberbier, T.; Asero, R.; Bindslev-Jensen, C.; Canonica, W.G.; Church, M.K.; Giménez-Arnau, A.M.; Grattan, C.E.; Kapp, A.; Maurer, M.; Merk, H.F.; Rogala, B.; Saini, S.; Sánchez-Borges, M.; Schmid-Grendelmeier, P.; Schünemann, H.; Staubach, P.; Vena, G.A.; Wedi, B.; Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy, 2009, 64, 1417-1426.
2. Zuberbier, T.; Asero, R.; Bindslev-Jensen, C.; Walter Canonica, G.; Church, M/K.; Giménez-Arnau, A.; Grattan, C.E.; Kapp, A.; Merk, H.F.; Rogala, B.; Saini, S.; Sánchez-Borges, M.; Schmid-Grendelmeier, P.; Schünemann, H.; Staubach, P.; Vena, G.A.; Wedi, B.; Maurer, M; Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy, 2009, 64, 1417-1426.
3. 2LEN task force report. Allergy, 2011, 66, 317-330.
4. Kaplan, A. Chronic urticaria and angioedema. N. Eng. J. Med., 2002, 346, 175-179.
5. Lipworth, B.J. Leukotriene-receptor antagonists. Lancet, 1999, 353, 57-62.
6. Brunetti, L.; Francavilla, R.; Miniello, V.L.; Platzer, M.H.; Rizzi, D.; Lospalluti, M.L.; Poulsen, L.K.; Armenio, L.; Skov, P.S. High prevalence of autoimmune urticaria in children with chronic urticaria. J. Allergy Clin. Immunol, 2004, 114, 922-927.
7. Takeda, T.; Sakurai, Y.; Takahagi, S.; Kato, J.; Yoshida, K.; Yoshioka, A.; Hide, M.; Shima, M. Increase of coagulation potential in chronic spontaneous urticaria. Allergy, 2011, 66, 428-433.
8. Huilan, Z.; Runxiang, L.; Bihua, L.; Qing, G. Role of the subgroups of T, B, natural killer lymphocyte and serum levels of interleukin-15, interleukin-21 and immunoglobulin E in the pathogenesis of urticaria. J. Dermatol, 2010, 37, 441-447.
9. Raap, U.; Wieczorek, D.; Gehring, M.; Pauls, I.; Ständer, S.; Kapp, A.; Wedi, B. Increased levels of serum IL-31 in chronic spontaneous urticaria. Exp. Dermatol, 2010, 19, 464-466.
10. Kasperska-Zajac, A.; Brzoza, Z.; Rogala, B. Increased concentration of platelet-derived chemokines in serum of patients with delayed pressure urticaria. Eur. Cytokine Netw., 2008, 19, 89-91.
11. Dos Santos, JC; Azor, M.H.; Nojima, V.Y.; Lourenço, F.D.; Prearo, E.; Maruta, C.W.; Rivitti, E.A.; da Silva Duarte, A.J.; Sato, M.N. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int. Immunopharmacol, 2008, 8, 1433-1440.
12. Chen, W.C.; Chiang, B.L.; Liu, H.E.; Leu, S.J.; Lee, Y.L. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria. J. Dermatol. Sci., 2008, 51, 121-130.
13. Lourenço, F.D.; Azor, M.H.; Santos, J.C.; Prearo, E.; Maruta, C.W.; Rivitti, E.A.; Duarte, A.J.; Sato, M.N. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br. J. Dermatol, 2008, 158, 979-986.
14. Caproni, M.; Giomi, B.; Melani, L.; Volpi, W.; Antiga, E.; Torchia, D.; Fabbri, P. Cellular infiltrate and related cytokines, chemokines, chemokine receptors and adhesion molecules in chronic autoimmune urticaria: comparison between spontaneous and autologous serum skin test induced wheal. Int. J Immunopathol. Pharmacol., 2006, 19, 507-515.
15. Puccetti, A.; Bason, C.; Simeoni, S.; Millo, E.; Tinazzi, E.; Beri, R.; Peterlana, D.; Zanoni, G.; Senna, G.; Corrocher, R.; Lunardi, C. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin. Exp. Allergy, 2005, 35, 1599-1607.
16. Kasperska-Zajac, A.; Rogala, B.; Nowakowski, M. Assessment of platelet activity as expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp. Dermatol., 2005, 14, 515-518.
17. Caproni, M.; Giomi, B.; Volpi, W.; Melani, L.; Schincaglia, E.; Macchia, D.; Manfredi, M.; D'Agata, A.; Fabbri, P. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin. Immunol., 2005, 114, 284-292.
18. Caproni, M.; Cardinali, C.; Giomi, B.; Antiga, E.; D'Agata, A.; Walter, S.; Fabbri, P. Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J. Dermatol. Sci., 2004, 36, 57-59.
19. Santos, J.C.; de Brito, C.A.; Futata, E.A.; Azor, M.H.; Orii, N.M.; Maruta, C.W.; Rivitti, E.A.; Duarte, A.J.; Sato, M.N. Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clin. Exp. Immunol., 2012, 167, 129-136.
20. Tedesco, F.; Pucillo, C. Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy, 2011, 66, 1538-1545.
21. Ferrer, M.; Nuñez-Córdoba, J.M.; Luquin, E.; Grattan, C.E.; De la Borbolla, J.M.; Sanz, M.L.; Schwartz, L.B. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin. Exp. Allergy, 2010, 40, 1760-1766.
22. Platzer, M.H.; Grattan, C.E.; Poulsen, L.K.; Skov, P.S. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy, 2005, 60, 1152-1156.
23. Asero, R.; Lorini, M.; Chong, S.U.; Zuberbier, T.; Tedeschi, A. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin. Exp. Allergy, 2004, 34, 1111-1114.
24. Di Leo, E.; Nettis, E.; Aloia, A.M.; Moschetta, M.; Carbonara, M.; Dammacco, F.; Vacca, A. Cyclosporin-A efficacy in chronic idiopathic urticaria. Int. J. Immunopathol. Pharmacol., 2011, 24, 195-200.
25. Boubouka, C.D.; Charissi, C.; Kouimintzis, D.; Kalogeromitros, D.; Stavropoulos, P.G.; Katsarou, A. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Acta Derm. Venereol., 2011, 91, 50-54.
26. Kessel, A.; Toubi, E. Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy, 2010, 65, 1478-1482.
27. Ohtsuka, T. Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria. Int. J. Dermatol., 2010, 49, 579-584.
28. Serhat Inaloz, H.; Ozturk, S.; Akcali, C.; Kirtak, N.; Tarakcioglu, M. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J. Dermatol., 2008, 35, 276-282.
29. K.V. Cyclosporine in chronic idiopathic urticaria with positive autologous serum skin test. Indian J. Dermatol., 2008, 53, 101-102.
30. Vena, G.A.; Cassano, N.; Colombo, D.; Peruzzi, E.; Pigatto, P. Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J. Am. Acad Dermatol., 2006, 55, 705-709.
31. Baskan, E.B.; Tunali, S.; Turker, T.; Saricaoglu, H. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. J. Dermatolog. Treat, 2004, 15, 164-168.
32. Loria, M.P.; Dambra, P.P.; D'Oronzio, L.; Nettis, E.; Pannofino, A.; Cavallo, E.; Ferrannini, A.; Tursi, A. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol. Immunotoxicol., 2001, 23, 205-213.
33. Darras, S.; Ségard, M.; Mortier, L.; Bonnevalle, A.; Thomas, P. Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy. Ann. Dermatol. Venereol, 2004, 131, 65-69.
34. Aydogan, K.; Karadogan, S.K.; Tunali, S.; Saricaoglu, H. Narrowband ultraviolet B (311nm, TL01) phototherapy in chronic ordinary urticaria. Int. J. Dermatol, 2012, 51, 98-103.
35. Engin, B.; Ozdemir, M.; Balevi, A.; Mevlitoglu, I. Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial. Acta Derm. Venereol, 2008, 88, 247-251.
36. Monfrecola, G.; de Paulis, A; Prizio, E.; Russo, I.; Carfora, M.; Santoianni, P.; Marone, G. In vitro effects of ultraviolet A on histamine release from human basophils. J. Eur. Acad Dermatol. Venereol, 2003, 17, 646-651.
37. Berroeta, L.; Clark, C; Ibbotson, S.H.; Ferguson, J.; Dawe, R.S. Narrow-band (TL-01) ultraviolet B phototherapy for chronic urticaria. Clin. Exp. Dermatol, 2004, 29, 97-98.
38. Nettis, E.; D'Erasmo, M.; Di Leo, E.; Calogiuri, G.; Montinaro, V.; Ferrannini, A.; Vacca, A. The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field. Mediators Inflamm., 2010, 2010.
39. Scadding, G.W.; Scadding, G.K. Recent advances in antileukotriene therapy. Curr. Opin. Allergy Clin. Immunol, 2010, 10, 370-376.
40. Rovati, G.E.; Capra, V. Cysteinyl-leukotriene receptors and cellular signals. Sci. World J., 2007, 7, 1375-1392.
41. Riccioni, G.; Bucciarelli, T.; Mancini, B.; Di Ilio, C; D'Orazio, N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr. Med. Chem., 2007, 14, 1966-1977.
42. Leonardi, S.; Marchese, G.; Marseglia, G.L.; La Rosa, M. Montelukast in allergic diseases beyond asthma. Allergy Asthma Proc, 2007, 28, 287-291.
43. McBayne, T.O.; Siddall, O.M. Montelukast treatment of urticaria. Ann. Pharmacother., 2006, 40, 939-942.
44. Asero, R.; Tedeschi, A.; Lorini, M. Leukotriene receptor antagonists in chronic urticaria. Allergy, 2001, 56, 456-457.
45. Di Lorenzo, G.; Pacor, M.L.; Mansueto, P.; Esposito Pellitteri, M.; Lo Bianco, C; Ditta, V.; Martinelli, N.; Rini, G.B. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J. Allergy Clin. Immunol, 2004, 114, 619-625.
46. Nettis, E.; Colanardi, M.C.; Paradiso, M.T.; Ferrannini, A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin. Exp. Allergy, 2004, 34, 1401-1407.
47. Nettis, E.; Colanardi, M.C.; Soccio, A.L.; Ferrannini, A.; Vacca, A. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. Br. J. Dermatol, 2006, 155, 1279-1282.
48. Godse, K.V. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J. Dermatol. Venereol. Leprol, 2006, 72, 312-314.
49. Sanada, S.; Tanaka, T.; Kameyoshi, Y.; Hide, M. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch. Dermatol. Res., 2005, 297, 134-138.
50. Erbagci, Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J. Allergy Clin. Immunol, 2002, 110, 484-488.
51. Mathias, S.D.; Crosby, R.D.; Zazzali, J.L.; Maurer, M.; Saini, S.S. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol, 2012, 108, 20-24.
52. Mathias, S.D.; Dreskin, S.C.; Kaplan, A.; Saini, S.S.; Spector, S.; Rosén, K.E. Development of a daily diary for patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol, 2010, 105, 142-148.
53. Kosnik, M.; Subic, T. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. Respir. Med., 2011, 105, S84-8.
54. Agcaoili, M.L.; Sumpaico, M.W.; Aleta, L.A.; Recto, M.P.; Abong, J.M. Montelukast in the treatment of chronic Urticaria: A randomized double blind, placebocontrolled study. Ann. Allergy Asthma Immunol., 2011, 107/5 SUPPL. 1(A17), 1081-1206.
55. Moriya, M.; Aihara, M.; Hirota, R.; Hirata, Y.; Ikinaga, N.; Takamura, N.; Kunimi, Y.; Uchida, T.; Ikezawa, Z. Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan. Arerugi, 2011, 60, 699-707.
56. Kumar, S. Effect of montelukast and levocetrizine for antihistamine resistence chronic utricaria. Allergy, 2010, 65, 457-458.
57. K.S. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J. Dermatolog. Treat, 2009, 20, 194-197.
58. Lehtimäki, L.; Petäys, T.; Haahtela, T. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study. Int. Arch Allergy Immunol., 2009, 149, 150-153.
59. Di Lorenzo, G.; D'Alcamo, A.; Rizzo, M.; Leto-Barone, M.S.; Bianco, C.L.; Ditta, V.; Politi, D.; Castello, F.; Pepe, I.; Di Fede, G.; Rini, G. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. J. Asthma Allergy, 2008, 9, 9-16.
60. Grattan, C.E.H.; Dawn, G.; Gibbs, S.; Francis, D.M. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin. Exp. Allergy, 2003, 33, 337-341.
61. Leonard, E.J. Two populations of human blood basophils: effect of prednisone on circulating numbers. J. Allergy Clin. Immunol, 1987, 79, 775-780.
62. Kawakami, A.; Suzukawa, M.; Koketsu, R.; Komiya, A.; Ohta, K.; Yamamoto, K.; Yamaguchi, M. Enhancement of basophil apoptosis by olopatadine and theophylline. Allergy Asthma Proc, 2008, 29, 322-8.
63. Grundmann, S.A.; Kiefer, S.; Luger, T.A.; Brehler, R. Delayed pressure urticaria - dapsone heading for first-line therapy? J. Dtsch. Dermatol. Ges., 2011, 9, 908-9012.
64. Vo, T.S.; Ngo, D.H.; Kim, S.K. Potential Targets for AntiInflammatory and Anti-Allergic Activities of Marine Algae: An Overview. Inflamm. Allergy Drug Targets, 2012, 11, 90-101.
65. Nualsanit, T.; Rojanapanthu, P.; Gritsanapan, W.; Kwankitpraniti, T.; Min, K.W.; Baek, S.J. Damnacanthal-induced anti-inflammation is associated with inhibition of NF-kB activity. Inflamm. Allergy Drug Targets, 2011, 10, 455-463.
66. Broderick, L.; Tourangeau, L.M.; Kavanaugh, A.; Wasserman, S.I. Biologic modulators in allergic and autoinflammatory diseases. Curr. Opin. Allergy Clin. Immunol, 2011, 11, 355-360.